Royal Bank of Canada’s LAVA Therapeutics LVTX Stock Holding History

Royal Bank of Canada’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-44,348	Closed	-$69K	–	7421
2025 Q3	$69K	Buy	+44,348	New	+$66.2K	﹤0.01%	5688

Royal Bank of Canada's LVTX Position: Q4 2025 in Review

Royal Bank of Canada sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 44,348 shares — an estimated $69K sold.

Royal Bank of Canada first reported a position in LVTX in Q3 2025 and held it in 1 quarter. The position peaked at $69K in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

Royal Bank of Canada reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
Royal Bank of Canada sold 44,348 LAVA Therapeutics shares in Q4 2025, an estimated $69K.
Royal Bank of Canada first reported a position in LAVA Therapeutics in Q3 2025 and held it in 1 quarter.
Royal Bank of Canada's LAVA Therapeutics position peaked at $69K in Q3 2025.
0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.